30 Jan, EOD - Indian

SENSEX 76759.81 (0.30)

Nifty 50 23249.5 (0.37)

Nifty Bank 49311.95 (0.30)

Nifty IT 42426.65 (-1.14)

Nifty Midcap 100 52714.25 (-0.01)

Nifty Next 50 62193.15 (0.08)

Nifty Pharma 21419.65 (1.21)

Nifty Smallcap 100 16560.5 (0.12)

30 Jan, EOD - Global

NIKKEI 225 39513.97 (0.25)

HANG SENG 20225.11 (0.14)

S&P 6105.25 (0.42)

LOGIN HERE

companylogoOmaxe Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 532880 | NSE Symbol : OMAXE | ISIN : INE800H01010 | Industry : Realty |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
07-Nov-2024 14-Nov-2024 Quarterly Results OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended on September 30 2024. Please find enclosed herewith the copy of intimation w.r.t. Appointment of M/s. DMK Associates as Secretarial Auditors for the Financial Year 2024-25. (As Per Bse Announcement Dated on 14.11.2024)
06-Aug-2024 13-Aug-2024 Quarterly Results OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30 2024. Please note that the Board of Directors of the Company, at its meeting held today, i.e. on August 13, 2024 (which commenced at 02:30 P.M. and concluded at 05:30 P.M.) considered and approved the businesses as mentioned in the attached intimation. (As Per BSE Announcement Dated on: 13/08/2024)
21-May-2024 28-May-2024 Nine Months Results OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve 1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31 2024. 2. Matter related to declaration of dividend on unlisted '0.1% Non-Cumulative Non-Convertible Redeemable Preference Shares' (NCPs) for the Financial Year 2023-24. Please find enclosed the copy of outcome of the Board Meeting held on May 28, 2024. (As Per BSE Announcement Dated on 28.05.2024) Please find enclosed herewith the intimation under regulation 31A(8)(b) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 29.05.2024)
02-Feb-2024 09-Feb-2024 Quarterly Results OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and nine months ended on December 31 2023 Please note that the Board of Directors of the Company, at its meeting held today, i.e. on February 09, 2024 (which commenced at 12:30 P.M. and concluded at 05:15 P.M.) considered and approved the businesses as mentioned in the attached intimation. (As per BSE Announcement Dated on 09/02/2024)
02-Nov-2023 09-Nov-2023 Quarterly Results OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Standalone and consolidated unaudited financial results of the Company for the quarter & half year ended September 30 2023 Please find enclosed herewith the update on closure of trading window. Please note that the Board of Directors of the Company, at its meeting held today, i.e. November 09, 2023 considered and approved, inter-alia, the following matters: 1. Standalone & Consolidated Unaudited Financial Results for the quarter ended September 30, 2023. 2. Appointment of Mr. Deshabandhu Rajesh Srikanta as Company Secretary and Compliance Officer of the Company in place of Mr. Vikas Khandelwal. 3. Re-appointment of M/s DMK Associates, Company Secretaries, as Secretarial Auditors of the Company for the Financial Year 2023-24. Please refer to the enclosed copy of outcome. Please find enclosed herewith the copy of unaudited financial results for the quarter ended on 30.09.2023 alongwith the Limited Review Reports thereon. Please find enclosed the Meeting updates with respect to: 1. Appointment of Mr. D B R Srikanta as Company Secretary & Compliance Officer of the Company in place of Mr. Vikas Khandelwal. 2. Appointment of M/s DMK & Associates as Secretarial Auditor of the Company for the FY 2023-24. (As Per BSE Announcement Dated on 09/11/2023)
03-Aug-2023 10-Aug-2023 Quarterly Results OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Pursuant to Regulation 29 and other relevant regulations if any of SEBI Listing Regulations please note that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday the 10th day of August 2023 to consider and approve inter alia standalone and consolidated unaudited financial results of the Company for the quarter ended on June 30 2023. Please note that the Board of Directors of the Company, at its meeting held today, i.e. August 10, 2023 (which commenced at 02:00 P.M. and concluded at 05:20 P.M.) considered and approved, inter-alia, the Standalone & Consolidated Unaudited Financial Results of the Company for the quarter ended June 30, 2023. The copy of the said results (Standalone & Consolidated) along with Limited Review Reports, issued by statutory auditors of the Company on said results (both, Standalone & Consolidated) dated August 10, 2023, are enclosed herewith. Please find attached herewith the copy of Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended June 30, 2023 along with Limited Review Reports thereon issued by statutory auditors. (As per BSE Announcement Dated on 10/08/2023)
19-May-2023 26-May-2023 Accounts OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2023 inter alia to consider and approve 1. Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended on March 31 2023. 2. Matter related to declaration of dividend on unlisted 0.1% Non-Cumulative Non-Convertible Redeemable Preference Shares (NCPS) for the financial year 2022-23. Please note that the Board of Directors at its meeting held today, i.e. May 26, 2023 considered and approved, inter-alia, the enclosed matters. (As per BSE Announcement Dated on 26/05/2023)
06-Feb-2023 13-Feb-2023 Quarterly Results OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve inter-alia the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended on December 31 2022. This is to inform you that the Board of Directors of the Company, at its meeting held today, i.e. February 13, 2023, has appointed of Mr. Vikas Khandelwal as Company Secretary and Compliance Officer of the Company designated as Key Managerial Personnel with effect from February 14, 2023 in place of Mr. Navin Jain, who has resigned from the position of Company Secretary and Compliance Officer of the Company with effect from the close of business hours on February 13, 2023. The disclosure required under SEBI (LODR) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 is enclosed herewith. This is to inform you that the Board of Directors of the Company, at its meeting held today, i.e. February 13, 2023, has inter-alia, considered and approved the following matters: 1. Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Nine Months ended December 31, 2022 and the Limited Review Reports thereon; 2. Appointment of Mr. Vikas Khandelwal as Company Secretary and Compliance Officer of the Company designated as Key Managerial Personnel with effect from February 14, 2023 in place of Mr. Navin Jain, who has resigned from the position of Company Secretary and Compliance Officer of the Company with effect from the close of business hours on February 13, 2023. The disclosure required under SEBI (LODR) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 is enclosed herewith. The Board Meeting was commenced at 11:30 A.M. and concluded at 5:05 P.M. with a vote of thanks to the Chair. This is to inform you that the Board of Directors at its meeting held today, i.e. February 13, 2023, has inter-alia, considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Nine Months ended December 31, 2022 and the Limited Review Reports thereon as submitted by the Statutory Auditors, M/s BSD & Co., Chartered Accountants. The copy of same is annexed herewith. (As Per BSE Announcement dated on 13.02.2023)
07-Nov-2022 14-Nov-2022 Quarterly Results OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Pursuant to Regulation 29 and other relevant Regulations if any of SEBI (LODR) Regulations 2015 please note that a meeting of the Board of Directors of the Company is scheduled to be held on Monday the 14th day of November 2022 to consider & approve inter-alia the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30 2022 at the recommendation of the Audit Committee which will consider and review the same at its meeting scheduled to be held on the same day prior to the meeting of the Board. Dear Sir/ Madam, This is to inform you that the Board of Directors at its meeting held today, i.e. November 14, 2022, has inter-alia considered and approved the enclosed matters, at the recommendation of Audit Committee/Nomination & Remuneration Committee, as the case may be. Further, we would like to inform you that the information as required under Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 with respect to Point 2, 3 & 4 of enclosed outcome shall be disclosed in due course of time. You are requested to take the same on record. This is to inform you that the Board of Directors at its meeting held today, i.e. November 14, 2022, has inter-alia considered and approved the Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2022 along with the Statement of Assets and Liabilities & Cash Flow statement on that date and the Limited Review Reports thereon as submitted by the Statutory Auditors, M/s BSD & Co., Chartered Accountants at the recommendation of Audit Committee. The copy of same is annexed herewith. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and in continuation to our disclosure vide Ref. No. OL/SE/448/NOV 2022-23 dated November 14, 2022, please find attached the required information with respect to: 1. Re-appointment of Secretarial Auditors; 2. Retirement of Chief Financial Officer of the Company; and 3. Appointment of Chief Financial Officer of the Company (As Per BSE Announcement Dated on 14.11.2022)
03-Aug-2022 10-Aug-2022 Quarterly Results OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 inter alia to consider and approve Dear Sir/Madam Pursuant to Regulation 29 and other relevant Regulations if any of SEBI (LODR) Regulations 2015 please note that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday the 10th day of August 2022 to consider & approve inter-alia the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30 2022 at the recommendation of the Audit Committee which will consider and review the same at its meeting scheduled to be held on the same day prior to the meeting of the Board. This is to inform you that the Board of Directors at its meeting held today, i.e. August 10, 2022, has inter-alia considered and approved the enclosed items, at the recommendation of Audit Committee/Nomination & Remuneration Committee, as the case may be. You are requested to take the same on record please. This is to inform you that the Board of Directors at its meeting held today, i.e. August 10, 2022, has inter-alia considered and approved the following, at the recommendation of Audit Committee/Nomination & Remuneration Committee, as the case may be: 1. Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter ended June 30, 2022 along with the Limited Review Report thereon as submitted by the Statutory Auditors, M/s BSD & Co., Chartered Accountants. The copy of same is appended below. 2. The Cost Statements along with other annexures and the Cost Audit Report thereon for the Financial Year 2021-22 as submitted by M/s S.K. Bhatt & Associates, Cost Auditors of the Company. Also, please refer to the enclosed document. The information as required under Para A of Part A of Schedule III of SEBI (LODR) Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 with respect to Point 3 to 5 of enclosed document is attached as Annexure I. (As Per BSE Announcement dated on 10.08.2022)
23-May-2022 30-May-2022 Accounts OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve Pursuant to Regulation 29 and other relevant Regulations if any of SEBI (LODR) Regulations 2015 please note that a meeting of the Board of Directors of the Company is scheduled to be held on Monday the 30th day of May 2022 inter-alia: 1. To consider & approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31 2022 and to adopt the Statutory Auditors Report on the same at the recommendation of the Audit Committee which will consider and review the same at its meeting scheduled to be held on the same day prior to the meeting of the Board; 2. To consider the matter related to declaration of dividend on its 0.1% non-cumulative non-convertible redeemable preference shares and final dividend on equity shares if any for the financial year 2021-22 at the recommendation of the Audit Committee; Please note that the Board of Directors at its meeting held today, i.e. May 30, 2022 has considered/ reviewed/ noted/ approved, as the case may be, the enclosed matters. Further, we would like to inform that the Company will publish the Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2022, in the newspapers in terms of Regulation 47(1)(b) of SEBI (LODR) Regulations, 2015 and the same shall also be available at the website of the Company i.e. www.omaxe.com. (As Per BSE Announcement Dated on 30/05/2022) The Board has recommended not to declare any dividend to the equity shareholders due to absence of profits for the Financial Year 2021-22. (As Per BSE Bulletin Dated on 31.05.2022)
19-Feb-2022 19-Feb-2022 Change in Directors Dear Sir/ Madam, This is to inform you that the Board of Directors, at its meeting held today i.e. February 19, 2022, at the recommendation of Nomination & Remuneration Committee and Audit Committee, has inter-alia, designated Mr. Atul Banshal- Director Finance as Whole Time Key Managerial Personnel (KMP) of the Company with immediate effect. The required information pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 are enclosed herewith.
07-Feb-2022 14-Feb-2022 Quarterly Results OMAXE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Pursuant to Regulation 29 and other relevant Regulations if any of SEBI (LODR) Regulations 2015 please note that a meeting of the Board of Directors of the Company is scheduled to be held on Monday the 14th day of February 2022 to consider & approve inter-alia the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended on December 31 2021 at the recommendation of the Audit Committee which will consider and review the same at its meeting scheduled to be held on the same day prior to the meeting of the Board. Dear Sir/ Madam, This is to inform you that Board of Director's at its meeting held today i.e. February 14, 2022, has inter-alia, considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter & nine months ended on December 31, 2021 and the Report on Limited Review, conducted by the Company's Statutory Auditors i.e. M/ s BSD & Co., Chartered Accountants, for the aforementioned period. The Board Meeting was commenced at 12:00 NOON and concluded at 05:15 PM with a vote of thanks to the Chair. (As Per BSE Announcement Dated 14.02.2022)
08-Nov-2021 12-Nov-2021 Quarterly Results Quarterly Results Dear Sir/ Madam, This is to inform you that Board of Directors at its meeting held today i.e. November 12, 2021, has inter-alia, considered and approved the following items: 1. Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2021 along with the statement of Assets and Liabilities & Cash Flow statement on that date and the Report on Limited Review, conducted by the Company's Statutory Auditors i.e. M/ s BSD & Co., Chartered Accountants 2. Appointment of M/s DMK Associates, Company Secretaries, as the Secretarial Auditor of the Company for the Financial Year 2021-22. Appointment of M/s DMK Associates, Company Secretaries, as the Secretarial Auditor of the Company for the Financial Year 2021-22 (As per BSE Announcement Dated on 12/11/2021)
30-Oct-2021 30-Oct-2021 Change in Directors Dear Sir/ Madam, This is to inform you that the Board of Directors at its meeting held today i.e. October 30, 2021, at the recommendation of Nomination & Remuneration Committee, has inter-alia, approved the following items: 1. Re-designation of Mr. Rohtas Goel as Chairman & Whole Time Director of the Company with immediate effect, subject to the approval of Shareholders at the General Meeting. 2. Re-designation of Mr. Mohit Goel, by appointing him as a Managing Director of the Company, from his present designation of CEO & Whole Time Director of the Company with immediate effect, subject to the approval of Shareholders at the General Meeting. Consequently, Mr. Mohit Goel ceased to be the CEO of the Company with immediate effect. Details as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 are attached herewith as an Annexure A.
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +